Buscar resultados de ensayos clínicos
Cystadenocarcinoma, Serous - 24 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: A Phase II Evaluation of Afatinibin Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma Condición: HER2/Neu+ Uterine Serous Carcinoma Fecha: 2015-07-02 Intervenciones: Drug: Afatinib Afatinib, 40 mg orally once daily on a 21 day cycle for the first 12 weeks, then every 28 |
Not yet recruiting |
Nombre del estudio: Proof-of-concept Study of Birinapant in Combination With Platinum Based Chemotherapy in Subjects With High Grade Serous Carcinomas Condición: Advanced Newly Diagnosed or Recurrent High Grade Serous Carcinomas (HGSC) Fecha: 2016-04-22 Intervenciones:
|
Completed |
Nombre del estudio: Papillary Serous Carcinoma of the Endometrium Condición: Endometrial Cancer Fecha: 2007-08-09 Intervenciones:
|
Completed |
Nombre del estudio: A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma Condición: Uterine Cancer Fecha: 2005-10-03 Intervenciones:
|
Completed |
Nombre del estudio: Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma Condición: Uterine Cancer Fecha: 2007-07-23 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer Condición:
|
Not yet recruiting |
Nombre del estudio: Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer Condición:
|
Not yet recruiting |
Nombre del estudio: Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer Condición:
|
Recruiting |
Nombre del estudio: To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers Condición:
|
Completed |
Nombre del estudio: Phase II ABT-888 With Cyclophosphamide Condición:
|